Skip to content
CVRXCVRx, Inc.

Earnings

When CVRx, Inc. reports, what it reported each quarter, and how the stock took the results.

26 quarters. Jun 30, 2020 to Sep 30, 2026. USD.

Next results · Q4 2026Projected

Feb 11, after the close

Thu, Feb 11, 2027in 85 days

Projected from its last 8 releases. The company has not named the day yet.

Quarter
Q4 2026 · Ends about Dec 31, 2026
10-K window
Feb 8 – 25

Read against Q4 2025

The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.

Revenue
$16.02M
Revenue, change from a year earlier: Q3 2026 −5.8%, Q2 2026 +15.6%, Q1 2026 +19.6%, Q4 2025 +4.4%
Net income
-$11.93M
Net income, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m
EPS
—
EPS, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q3 2025 n/m

Quarter by quarter

Q3 2026$13.83M−5.8% vs Q3 2025

Latest results

  1. Q3 2026Nov 5, 2026, after the closeThe release38.6%by the close of Nov 6
    Revenue
    $13.83M
    −5.8%
    Net income
    -$14.16M
    N/M
    EPS
    -$0.52
    N/M
    CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced its financial and operating results for the third quarter of 2026.
  2. Q2 2026Aug 6, 2026, after the closeThe release59.8%by the close of Aug 7
    Revenue
    $15.71M
    +15.6%
    Net income
    -$14.04M
    N/M
    EPS
    -$0.53
    N/M
  3. Q1 2026May 11, 2026, after the closeThe release23.7%by the close of May 12
    Revenue
    $14.77M
    +19.6%
    Net income
    -$13.12M
    N/M
    EPS
    -$0.50
    N/M
  4. Q4 2025Feb 12, 2026, after the closeThe release12.0%by the close of Feb 13
    Revenue
    $16.02M
    +4.4%
    Net income
    -$11.93M
    N/M
    EPS
    —
    —

All quarters

PeriodEndedAnnouncedFiledLagFormRevenueΔ yoyEPS dil.MoveSource trail
FY 2026
Q3 2026Sep 30, 2026Nov 5, 2026 · after-hoursNov 5, 202636 d10-Q$13.83M−5.8%-$0.5238.6%
Q2 2026Jun 30, 2026Aug 6, 2026 · after-hoursAug 6, 202637 d10-Q$15.71M+15.6%-$0.5359.8%
Q1 2026Mar 31, 2026May 11, 2026 · after-hoursMay 12, 202642 d10-Q$14.77M+19.6%-$0.5023.7%
FY 2025
Q4 2025derivedDec 31, 2025Feb 12, 2026 · after-hoursFeb 13, 202644 d10-K$16.02M+4.4%—12.0%
Q3 2025Sep 30, 2025Nov 5, 2025 · after-hoursNov 6, 202537 d10-Q$14.69M+9.8%-$0.49+2.9%
Q2 2025Jun 30, 2025Aug 4, 2025 · after-hoursAug 5, 202536 d10-Q$13.59M+15.1%-$0.5710.0%
Q1 2025Mar 31, 2025May 8, 2025 · after-hoursMay 9, 202539 d10-Q$12.35M+14.7%-$0.5339.1%
FY 2024
Q4 2024derivedDec 31, 2024Feb 4, 2025 · after-hoursFeb 18, 202549 d10-K$15.34M+35.7%—6.8%
Q3 2024Sep 30, 2024Oct 29, 2024 · after-hoursNov 1, 202432 d10-Q$13.37M+27.2%-$0.57+30.8%
Q2 2024Jun 30, 2024Jul 29, 2024 · after-hoursAug 2, 202433 d10-Q$11.81M+24.3%-$0.65—
Q1 2024Mar 31, 2024Apr 30, 2024 · after-hoursMay 10, 202440 d10-Q$10.77M+35.0%-$1.0445.3%
Earlier years, FY 2020 to FY 2023

Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Source filings

10-QNov 5, 2026071075
10-QAug 6, 2026054336
10-QMay 12, 2026059023
10-KFeb 13, 2026014708
10-QNov 6, 2025107378
10-QAug 5, 2025010186
10-QMay 9, 2025007077
10-KFeb 18, 2025001055
10-QNov 1, 2024014078
10-QAug 2, 2024010719

Provenance

ProvenanceData status and checks

CVRx, Inc. · CIK 1235912 · Engraved from SEC EDGAR